Quantitative real-time PCR confirmed the significant upregulation of CTPS2 in CLL patients compared to purified normal CD19 + B cells derived from healthy donors, with an over tenfold increase (Fig. 1A, p <0.01). Here, CD19 is linked to B-cell chronic lymphocytic leukemia.